Cantor Lops PT on Intuitive Surgical (ISRG) to $420; Not Yet at Inflection Point, N-T Catalysts Still Stagnant
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- US stock futures dip as oil breaches $100 mark for the first time since mid-year
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Intuitive Surgical (ISRG) Remains Outperform at Barrington Despite Deceleration
April 23, 2014 3:26 PM EDTBarrington Research maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $650. Analyst Charley R. Jones noted that guidance reflects deceleration but he is a buyer on weakness.
"ISRG reported weaker-than-expected Q1/14 results and guidance for the remainder... More
Intuitive Surgical (ISRG) Q1 'a Bust' - Northland Capital Markets
April 23, 2014 8:26 AM EDTNorthland Capital Markets analyst Suraj Kalia reiterated an Underperform rating and $275 price target on Intuitive Surgical (NASDAQ: ISRG) calling Q1 'a bust.'
Kalia commented, "Intuitive's Q1-14 call yesterday had some ominous signs of a different story moving forward. Revs @ $465M completely... More
Intuitive Surgical (ISRG) Target, Estimates Slashed at Jefferies Post Q1; 'Buy' Maintained
April 23, 2014 7:01 AM EDTJefferies analyst Imron Zafar cut estimates and his price target on Intuitive Surgical (NASDAQ: ISRG) from $595 to $465 following weak Q1 results.
Zafar states, "1Q was weak across the board, and while a procedure guidance... More
Intuitive Surgical, Inc. (ISRG) Posts Q1 EPS of $1.13
April 22, 2014 4:47 PM EDTIntuitive Surgical, Inc. (NASDAQ: ISRG) reported Q1 EPS of $1.13, $2.14 worse than the analyst estimate of $3.27. Revenue for the quarter came in at $465 million versus the consensus estimate of $507.04 million.
First quarter 2014 instrument and accessory revenue decreased by approximately 2% to $255 million compared with $261 million for the first quarter of 2013. The decrease in revenue was driven by lower instrument and... More
Intuitive Surgical, Inc. (ISRG) Receives FDA 510(k) Clearance of da Vinci Sp Surgical System
April 22, 2014 8:31 AM EDTIntuitive Surgical, Inc. (Nasdaq: ISRG) announced it has received FDA 510(k) clearance for the da Vinci Sp Surgical System, which is designed to expand the Company's single-incision product offering. This initial clearance is specific to urologic surgical procedures that are appropriate for a... More
